α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

α-Synuclein in Lewy bodies

Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382 · see citing works

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961 · see citing works

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop

McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960 · see citing works

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

(1998) · Europe PMC (PubMed Central) · Cited by 1,594 · see citing works

Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease

HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542 · see citing works

Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease

Conway, K. A., Harper, J. D., & Lansbury, P. T. (1998) · Nature Medicine · doi:10.1038/3311 · Cited by 1,501 · see citing works

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

Uéda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto, M., Otero, D. A., Kondo, J. D. M., Ihara, Y., & Saitoh, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11282 · Cited by 1,469 · see citing works

Greenfield's Neuropathology

(1964) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1964.tb115841.x · Cited by 1,411 · see citing works

The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., Rohan de Silva, H. A., Kittel, A., & Saitoh, T. (1995) · Neuron · doi:10.1016/0896-6273(95)90302-x · Cited by 1,316 · see citing works

Identification of two distinct synucleins from human brain

Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080 · see citing works

The Lewy body variant of Alzheimer's disease: A clinical and pathologic entity

Hansen, L., Salmon, D., Galasko, D., Masliah, E., Katzman, R., DeTeresa, R., Thal, L., Pay, M. M., Hofstetter, R., Klauber, M., et al. (1990) · Neurology · doi:10.1212/wnl.40.1.1 · Cited by 1,068 · see citing works

α-Synuclein Fibrillogenesis Is Nucleation-dependent

Wood, S. J., Wypych, J., Steavenson, S., Louis, J., Citron, M., & Biere, A. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19509 · Cited by 719 · see citing works

Senile dementia of Lewy body type

Perry, R. H., Irving, D., Blessed, G., FAIRBAIRN, A. F., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 573 · see citing works

Lewy Bodies Contain Altered α-Synuclein in Brains of Many Familial Alzheimer's Disease Patients with Mutations in Presenilin and Amyloid Precursor Protein Genes

Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65722-7 · Cited by 533 · see citing works

Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.

Takeda, A., Mallory, M. E., Sundsmo, M. P., Honer, W. G., Hansen, L. A., & Masliah, E. (1998) · Europe PMC (PubMed Central) · Cited by 404 · see citing works

Nigral and Cortical Lewy Bodies and Dystrophic Nigral Neurites in Parkinsonʼs Disease and Cortical Lewy Body Disease Contain α-synuclein Immunoreactivity

Irizarry, M. C., Growdon, W., Gómez‐Isla, T., Newell, K. L., George, J. M., Clayton, D. F., & Hyman, B. T. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199804000-00005 · Cited by 394 · see citing works

α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356

Jensen, P. H., Hager, H., Nielsen, M. S., Højrup, P., Gliemann, J., & Jakes, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25481 · Cited by 377 · see citing works

Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050918 · Cited by 347 · see citing works

Diffuse lewy body disease in Japan

Kosaka, K. (1990) · Journal of Neurology · doi:10.1007/bf00314594 · Cited by 335 · see citing works

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease

Wakabayashi, K., Matsumoto, K., Takayama, K., Yoshimoto, M., & Takahashi, H. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00891-4 · Cited by 331 · see citing works

Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease

Dickson, D. W., Ruan, D. T., Crystal, H., Mark, M. H., Davies, P., Kress, Y., & Yen, S. H. (1991) · Neurology · doi:10.1212/wnl.41.9.1402 · Cited by 293 · see citing works

Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

Arima, K., Uéda, K., Sunohara, N., Hirai, S., Izumiyama, Y., Tonozuka-Uehara, H., & Kawai, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00734-3 · Cited by 244 · see citing works

Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies

Arima, K., Hirai, S., Sunohara, N., Aoto, K., Izumiyama, Y., Uéda, K., Ikeda, K., & Kawai, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01848-x · Cited by 209 · see citing works

Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.

Lennox, G. G., Lowe, J. S., Morrell, K., Landon, M., & Mayer, R. J. (1989) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.1.67 · Cited by 192 · see citing works

Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders

Schmidt, M. L., Martin, J. A., Lee, V. M. ‐., & Trojanowski, J. Q. (1996) · Acta Neuropathologica · doi:10.1007/s004010050454 · Cited by 140 · see citing works

Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein

Jakes, R., Crowther, R. A., Lee, V. M. ‐., Trojanowski, J. Q., Iwatsubo, T., & Goedert, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00411-5 · Cited by 103 · see citing works

α-Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism-Dementia Complex of Guam

Yamazaki, M., Arai, Y., Baba, M., Iwatsubo, T., Mori, O., Katayama, Y., & Oyanagi, K. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.7.585 · Cited by 98 · see citing works

Lewy bodies are located preferentially in limbic areas in diffuse Lewy body disease

Rezaie, P., Cairns, N. J., Chadwick, A. J., & Lantos, P. L. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12775-0 · Cited by 80 · see citing works

Neuropathologic Evidence that the Lewy Body Variant of Alzheimer Disease Represents Coexistence of Alzheimer Disease and Idiopathic Parkinson Disease

Brown, D. F., Dababo, M. A., Bigio, E. H., Risser, R. C., Eagan, K. P., Hladik, C. L., & White, C. L. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199801000-00006 · Cited by 66 · see citing works

Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease

Iseki, E., Marui, W., Kosaka, K., & Uéda, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00178-0 · Cited by 65 · see citing works

Parkinson's disease and dementia

Ostroaky-Solí, F., Navarro, I. M., & Zarabozo, D. (1989) · Neurology · doi:10.1212/wnl.39.4.610-b · Cited by 6 · see citing works

[Parkinson's disease and dementia].

Li, J., Zhang, W., & Ye, H. (1998) · PubMed · Cited by 2 · see citing works

Untitled work

Price (1999) · doi:10.1002/1531-8249(199903)45:3

Conformational constraints for amyloid fibrillation: the importance of being unfolded

Uversky, V. N., & Fink, A. L. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2003.12.008 · Cited by 1,012 · see citing works

Neuroinflammation as a common feature of neurodegenerative disorders

Guzman-Martinez, L., Maccioni, R. B., Andrade, V., Navarrete, L. P., Pastor, M. G., & Ramos-Escobar, N. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01008 · Cited by 702 · see citing works

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1314-y · Cited by 676 · see citing works

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

Jellinger, K. A. (2011) · Movement Disorders · doi:10.1002/mds.23795 · Cited by 448 · see citing works

Colocalization of Tau and Alpha-Synuclein Epitopes in Lewy Bodies

Ishizawa, T., Mattila, P. M., Davies, P., Wang, D., & Dickson, D. W. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.389 · Cited by 391 · see citing works

Alpha-synuclein biology in Lewy body diseases

Kim, W. S., Kågedal, K., & Halliday, G. M. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0073-2 · Cited by 376 · see citing works

α-synuclein in the pathophysiology of Alzheimer’s disease

Twohig, D., & Nielsen, H. M. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0320-x · Cited by 374 · see citing works

Alzheimer Disease With Amygdala Lewy Bodies: A Distinct Form of α-Synucleinopathy

Uchikado, H., Lin, W.-L., DeLucia, M. W., & Dickson, D. W. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000225908.90052.07 · Cited by 359 · see citing works

Accumulation of Phosphorylated α-Synuclein in Aging Human Brain

Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., et al. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.6.644 · Cited by 351 · see citing works

Neuropathological spectrum of synucleinopathies

Jellinger, K. A. (2003) · Movement Disorders · doi:10.1002/mds.10557 · Cited by 338 · see citing works

Biophysics of Parkinsons Disease: Structure and Aggregation of α- Synuclein

Uversky, V. N., & Eliezer, D. (2009) · Current Protein and Peptide Science · doi:10.2174/138920309789351921 · Cited by 320 · see citing works

Clinicopathologic Correlations in a Large Alzheimer Disease Center Autopsy Cohort: Neuritic Plaques and Neurofibrillary Tangles "Do Count" When Staging Disease Severity

Nelson, P. T., Jicha, G. A., Schmitt, F. A., Liu, H., Davis, D. G., Mendiondo, M. S., Abner, E. L., & Markesbery, W. R. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31815c5efb · Cited by 292 · see citing works

α‐Synuclein contributes to GSK‐3β‐catalyzed Tau phosphorylation in Parkinson's disease models

Duka, T., Duka, V., Joyce, J. N., & Sidhu, A. (2009) · The FASEB Journal · doi:10.1096/fj.08-120410 · Cited by 276 · see citing works

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

Jellinger, K. A., & Attems, J. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0347-5 · Cited by 265 · see citing works

Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease

Dev, K. K. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00140-0 · Cited by 262 · see citing works

Lewy body-related ?-synucleinopathy in the aged human brain

Jellinger, K. A. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0138-7 · Cited by 253 · see citing works

Patterns and stages of α-synucleinopathy

ZACCAI, J. H., Brayne, C., McKeith, I. G., Matthews, F. E., & Ince, P. G. (2008) · Neurology · doi:10.1212/01.wnl.0000306697.48738.b6 · Cited by 242 · see citing works

Intrinsic disorder in proteins associated with neurodegenerative diseases

Vladimir, N. (2009) · Frontiers in bioscience · doi:10.2741/3594 · Cited by 234 · see citing works

Tau Protein Interaction Partners and Their Roles in Alzheimer’s Disease and Other Tauopathies

Sinsky, J., Pichlerova, K., & Hanes, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179207 · Cited by 220 · see citing works

Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia

Wills, J., Jones, J. M., Haggerty, T., Duka, V., Joyce, J. N., & Sidhu, A. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.06.017 · Cited by 211 · see citing works

Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro

Necula, M., Chirita, C. N., & Kuret, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308231200 · Cited by 211 · see citing works

α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study

Jellinger, K. A. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0725-y · Cited by 201 · see citing works

Early-Onset Alzheimer’s Disease: What Is Missing in Research?

Ayodele, T., Rogaeva, E. A., Kurup, J. T., Beecham, G. W., & Reitz, C. (2021) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-020-01090-y · Cited by 198 · see citing works

Amyloidogenesis of Natively Unfolded Proteins

Uversky, V. N. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533312 · Cited by 187 · see citing works

Confluence of α-Synuclein, Tau, and β-Amyloid Pathologies in Dementia With Lewy Bodies

Colom‐Cadena, M., Gelpí, E., Charif, S., Belbin, O., Blesa, R., Martı́, M. J., Clarimón, J., & Lleó, A. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000018 · Cited by 184 · see citing works

Alzheimer's disease and Down's syndrome: roles of APP, trophic factors and ACh

Ole Isacson, A. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02037-4 · Cited by 187 · see citing works

Pathology associated with sporadic Parkinson’s disease — where does it end?

Braak, H., Müller, C. M., Rüb, U., Ackermann, H., Bratzke, H., de Vos, R. A. I., & Tredici, K. D. (2006) · Springer eBooks · doi:10.1007/978-3-211-45295-0_15 · Cited by 182 · see citing works

Neuropathology of multiple system atrophy: New thoughts about pathogenesis

Jellinger, K. A. (2014) · Movement Disorders · doi:10.1002/mds.26052 · Cited by 181 · see citing works

Late-onset vs nonmendelian early-onset Alzheimer disease

Reitz, C., Rogaeva, E., & Beecham, G. (2020) · Neurology: Genetics · doi:10.1212/nxg.0000000000000512 · Cited by 145 · see citing works

α-Synuclein and the Lewy body disorders

Dickson, D. W. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00001 · Cited by 163 · see citing works

Tau and transgenic animal models

Götz, J. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00055-8 · Cited by 161 · see citing works

Alpha-Synuclein Lesions in Normal Aging, Parkinson Disease, and Alzheimer Disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA)

Mikolaenko, I., Pletniková, O., Kawas, C. H., O’Brien, R., Resnick, S. M., Crain, B. J., & Troncoso, J. C. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.2.156 · Cited by 161 · see citing works

Identification of the region of non‐Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity

Bodles, A. M., Guthrie, D. J. S., Greer, B., & Irvine, G. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00408.x · Cited by 148 · see citing works

Phosphorylation of tau and α-synuclein in synaptic-enriched fractions of the frontal cortex in Alzheimer’s disease, and in Parkinson’s disease and related α-synucleinopathies

Muntané, G., Dalfó, E., Martı́nez, A., & Ferrer, I. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.01.030 · Cited by 143 · see citing works

Mice expressing the A53T mutant form of human alpha‐synuclein exhibit hyperactivity and reduced anxiety‐like behavior

Graham, D. R., & Sidhu, A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22331 · Cited by 137 · see citing works

Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's DiseasesPreprint

Braak, H., & Tredici, K. D. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023630 · Cited by 129 · see citing works

Regional Distribution of α-Synuclein Pathology in Unimpaired Aging and Alzheimer Disease

Parkkinen, L., Soininen, H. S., & Alafuzoff, I. I. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.4.363 · Cited by 129 · see citing works

Interaction between pathogenic proteins in neurodegenerative disorders

Jellinger, K. A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01507.x · Cited by 128 · see citing works

A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease

Borghammer, P., Just, M. K., Horsager, J., Skjærbæk, C., Raunio, A., Kok, E. H., Savola, S., Murayama, S., Saito, Y., Myllykangas, L., et al. (2022) · npj Parkinson's Disease · doi:10.1038/s41531-022-00436-2 · Cited by 127 · see citing works

General aspects of neurodegeneration

Jellinger, K. A. (2003) · Journal of Neural Transmission. Supplementa · doi:10.1007/978-3-7091-0643-3_7 · Cited by 126 · see citing works

α-Synuclein modulates tau spreading in mouse brains

Bassil, F., Meymand, E. S., Brown, H. J., Xu, H. W., Cox, T. O., Pattabhiraman, S., Maghames, C. M., Wu, Q., Zhang, B., Trojanowski, J. Q., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192193 · Cited by 111 · see citing works

Fatty acid incorporation is decreased in astrocytes cultured from α‐synuclein gene‐ablated mice

Castagnet, P. I., Golovko, M. Y., Barceló‐Coblijn, G., Nussbaum, R. L., & Murphy, E. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03247.x · Cited by 108 · see citing works

Alpha-synuclein: a pathological factor with Aβ and tau and biomarker in Alzheimer’s disease

Shim, K. H., Kang, M. J., Youn, Y. C., An, S. S. A., & Kim, S. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01150-0 · Cited by 98 · see citing works

Functional and Pathological Effects of α-Synuclein on Synaptic SNARE Complexes

Gao, V., Briano, J. A., Komer, L. E., & Burré, J. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167714 · Cited by 96 · see citing works

Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies

Katsuse, O., Iseki, E., Marui, W., & Kosaka, K. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00037-6 · Cited by 96 · see citing works

α-Synuclein in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment

Korff, A., Liu, C., Ginghina, C., Shi, M., Zhang, J., & Initiative, F. T. A. D. N. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-130458 · Cited by 95 · see citing works

Relationship of phosphorylated α-synuclein and tau accumulation to Aβ deposition in the cerebral cortex of dementia with Lewy bodies

Obi, K., Akiyama, H., Kondo, H., Shimomura, Y., Hasegawa, M., Iwatsubo, T., Mizuno, Y., & Mochizuki, H. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.019 · Cited by 91 · see citing works

Co-localization of tau and α-synuclein in the olfactory bulb in Alzheimer’s disease with amygdala Lewy bodies

Fujishiro, H., Tsuboi, Y., Lin, W.-L., Uchikado, H., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0383-1 · Cited by 93 · see citing works

Lewy-related pathology exhibits two anatomically and genetically distinct progression patterns: a population-based study of Finns aged 85+

Raunio, A., Kaivola, K., Tuimala, J., Kero, M., Oinas, M., Polvikoski, T. M., Paetau, A. E., Tienari, P. J., & Myllykangas, L. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02071-3 · Cited by 89 · see citing works

Unique α-synuclein pathology within the amygdala in Lewy body dementia: implications for disease initiation and progression

Sorrentino, Z. A., Goodwin, M. S., Riffe, C. J., Dhillon, J.-K. S., Xia, Y., Gorion, K.-M. M., Vijayaraghavan, N., McFarland, K. N., Golbe, L. I., Yachnis, A. T., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0787-2 · Cited by 84 · see citing works

Immunohistochemical comparison of α- and β-synuclein in adult rat central nervous system

Mori, F., Tanji, K., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02643-4 · Cited by 84 · see citing works

Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro

Marotta, N. P., Ara, J. E., Uemura, N., Lougee, M. G., Meymand, E. S., Zhang, B., Petersson, E. J., Trojanowski, J. Q., & Lee, V. M. ‐. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01288-2 · Cited by 80 · see citing works

Tauopathic Changes in the Striatum of A53T α-Synuclein Mutant Mouse Model of Parkinson's Disease

Wills, J., Credle, J. J., Haggerty, T., Lee, J., Oaks, A. W., & Sidhu, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017953 · Cited by 79 · see citing works

Morphological substrates of parkinsonism with and without dementia: a retrospective clinico-pathological study

Jellinger, K. A. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_12 · Cited by 78 · see citing works

Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer?s disease

Marui, W., Iseki, E., Kato, M., Akatsu, H., & Kosaka, K. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0869-4 · Cited by 77 · see citing works

Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease

Roy, B., & Jackson, G. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu011 · Cited by 75 · see citing works

Rapid and Direct Transport of Cell Surface APP to the Lysosome defines a novel selective pathway

Lorenzen, A., Samosh, J., Dewark, K. V., Anborgh, P. H., Seah, C., Magalhães, A. C., Cregan, S. P., Ferguson, S. S. G., & Pasternak, S. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-11 · Cited by 75 · see citing works

Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies

Duda, J. E. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074677 · Cited by 73 · see citing works

Amidst an amygdala renaissance in Alzheimer’s disease

Stouffer, K. M., Grande, X., Düzel, E., Johansson, M., Creese, B., Witter, M. P., Miller, M. I., Wisse, L. E. M., & Berron, D. (2023) · Brain · doi:10.1093/brain/awad411 · Cited by 70 · see citing works

Extracellular α-Synuclein Leads to Microtubule Destabilization via GSK-3β-Dependent Tau Phosphorylation in PC12 Cells

Gąssowska-Dobrowolska, M., Czapski, G. A., Pająk, B., Cieślik, M., Lenkiewicz, A. M., & Adamczyk, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094259 · Cited by 68 · see citing works

The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease

for the Dominantly Inherited Alzheimer Network (DIAN), Twohig, D., Rodriguez-Vieitez, E., Sando, S. B., Berge, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., Patra, K., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0624-z · Cited by 68 · see citing works

APOE4 exacerbates α-synuclein seeding activity and contributes to neurotoxicity in Alzheimer’s disease with Lewy body pathology

Jin, Y., Li, F., Sonoustoun, B., Kondru, N. C., Martens, Y. A., Qiao, W., Heckman, M. G., Ikezu, T. C., Li, Z., Burgess, J. D., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02421-8 · Cited by 69 · see citing works

Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease

Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002607 · Cited by 64 · see citing works

Interaction between -Synuclein and Other Proteins in Neurodegenerative Disorders

Jellinger, K. A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/371893 · Cited by 63 · see citing works

Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future

Shakir, M., & Dugger, B. N. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab122 · Cited by 56 · see citing works

The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies

Hanger, D. P., Gibb, G., de Silva, R., Boutajangout, A., Brion, J., Révész, T., Lees, A. J., & Anderton, B. H. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03611-6 · Cited by 55 · see citing works

Dementia with Lewy bodies: Reclassification of pathological subtypes and boundary with Parkinson's disease or Alzheimer's disease

Iseki, E. (2004) · Neuropathology · doi:10.1111/j.1440-1789.2003.00530.x · Cited by 54 · see citing works

Characteristics of alpha-synucleinopathy in centenarians

Ding, Z., Wang, Y., Jiang, Y., Hashizume, Y., Yoshida, M., Mimuro, M., Inagaki, T., & Iwase, T. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0015-y · Cited by 53 · see citing works

Development and validation of an expanded antibody toolset that captures alpha-synuclein pathological diversity in Lewy body diseases

Altay, M. F., Kumar, S. T., Burtscher, J., Jagannath, S., Strand, C., Miki, Y., Parkkinen, L., Holton, J. L., & Lashuel, H. A. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00604-y · Cited by 48 · see citing works

Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain

Fu, Y., He, Y. Z., Phan, K., Bhatia, S., Pickford, R., Wu, P., Dzamko, N. L., Halliday, G. M., & Kim, W. S. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01469-7 · Cited by 53 · see citing works

Secondary Protein Aggregates in Neurodegenerative Diseases: Almost the Rule Rather than the Exception

Moda, F., Ciullini, A., Dellarole, I. L., Lombardo, A., Campanella, N., Bufano, G., Cazzaniga, F. A., & Giaccone, G. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810255 · Cited by 48 · see citing works

Selective reduction of soluble Tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study

Zhukareva, V. A., Sundarraj, S., Mann, D. M. A., Sjögren, M. J. C., Blenow, K., Clark, C. M., McKeel, D. W., Goate, A., Lippa, C. F., Vonsattel, J., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-002-0668-8 · Cited by 51 · see citing works

Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration

Cortés, N., Andrade, V., Guzmán-Martínez, L., Estrella, M., & Maccioni, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19040956 · Cited by 41 · see citing works

α-Synuclein: A potent inducer of tau pathology

Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 43 · see citing works

NACP/α-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC)

Yokota, O., Terada, S., Ishizu, H., Tsuchiya, K., Kitamura, Y., Ikeda, K., Uéda, K., & Kuroda, S. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0545-5 · Cited by 41 · see citing works

Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers

Thal, D. R., Poesen, K., Vandenberghe, R. R., & Meyer, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00819-y · Cited by 47 · see citing works

NACP/α-Synuclein, NAC, and β-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases

Yokota, O., Terada, S., Ishizu, H., Ujike, H., Ishihara, T., Nakashima, H., Yasuda, M., Kitamura, Y., Uéda, K., Checler, F., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0596-7 · Cited by 42 · see citing works

On the ‘classification’ of neurodegenerative disorders: discrete entities, overlap or continuum?

Armstrong, R. A. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.30521 · Cited by 40 · see citing works

Occurrence of a-synuclein pathology in the cerebellum of Guamanian patients with parkinsonism-dementia complex

Sebeo, J., Hof, P. R., & Perl, D. P. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0840-4 · Cited by 39 · see citing works

Interactions Between α-Synuclein and Tau Protein: Implications to Neurodegenerative Disorders

Li, X., James, S., & Lei, P. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0829-1 · Cited by 38 · see citing works

α-Synuclein, Aβ and Alzheimer's disease

Wirths, O. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00339-1 · Cited by 37 · see citing works

Region-specific tauopathy and synucleinopathy in brain of the alpha-synuclein overexpressing mouse model of Parkinson's disease

Kaul, T. K., Credle, J. J., Haggerty, T., Oaks, A. W., Masliah, E., & Sidhu, A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-79 · Cited by 37 · see citing works

α-Synuclein seeding amplification assays for diagnosing synucleinopathies: an innovative tool in clinical implementation

Kuang, Y., Mao, H., Huang, X., Chen, M., Dai, W. H., Gan, T., Wang, J., Sun, H., Lin, H., Liu, Q., et al. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00449-2 · Cited by 36 · see citing works

Transcriptional profiling of multiple system atrophy cerebellar tissue highlights differences between the parkinsonian and cerebellar sub-types of the disease

Piras, I. S., Bleul, C., Schrauwen, I., Talboom, J. S., Llaci, L., Both, M. D. D., Naymik, M., Halliday, G. M., Bettencourt, C., Holton, J. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00950-5 · Cited by 36 · see citing works

Heterogeneity of Multiple System Atrophy: An Update

Jellinger, K. A. (2022) · Biomedicines · doi:10.3390/biomedicines10030599 · Cited by 36 · see citing works

Tau Seeding Mouse Models with Patient Brain-Derived Aggregates

Robert, A., Schöll, M., & Vogels, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116132 · Cited by 35 · see citing works

Heterotypic interactions in amyloid function and disease

Konstantoulea, K., Louros, N. N., Rousseau, F., & Schymkowitz, J. W. H. (2021) · FEBS Journal · doi:10.1111/febs.15719 · Cited by 32 · see citing works

Lewy‐ and Alzheimer‐type pathologies in midbrain and cerebellum across the Lewy body disorders spectrum

Sierra, M., Gelpí, E., Martı́, M. J., & Compta, Y. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12308 · Cited by 30 · see citing works

Neuropathology of Parkinson’s Disease

Jellinger, K. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-08046-8_2 · Cited by 30 · see citing works

A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury

Zhao, X., Zeng, W., Xu, H. W., Sun, Z., Hu, Y., Peng, B., McBride, J. D., Duan, J., Deng, J., Zhang, B., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo6889 · Cited by 31 · see citing works

Microglia-driven inflammation induces progressive tauopathies and synucleinopathies

Lee, S. H., Bae, E.-J., Park, S. J., & Lee, S. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01450-z · Cited by 29 · see citing works

Mixed pathologies in pancreatic β cells from subjects with neurodegenerative diseases and their interaction with prion protein

Martínez-Valbuena, I., Valenti‐Azcarate, R., Amat, I., Marcilla, I., Martí‐Andrés, G., Caballero, M. C., Riverol, M., Tuñon, M.-T., Fraser, P. E., & Luquín, M. R. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01171-0 · Cited by 29 · see citing works

Dementia with Lewy Bodies and Parkinson's Disease Dementia

Ince, P. G. (2011) · doi:10.1002/9781444341256.ch22 · Cited by 29 · see citing works

Spinal cord involvement in Lewy body-related α-synucleinopathies

Nardone, R., Höller, Y., Brigo, F., Versace, V., Sebastianelli, L., Florea, C., Schwenker, K., Golaszewski, S. M., Saltuari, L. L., & Trinka, E. (2019) · Journal of Spinal Cord Medicine · doi:10.1080/10790268.2018.1557863 · Cited by 28 · see citing works

Alpha-synuclein measured in cerebrospinal fluid from patients with Alzheimer’s disease, mild cognitive impairment, or healthy controls: a two year follow-up study

Berge, G., Sando, S. B., Albrektsen, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., & White, L. R. (2016) · BMC Neurology · doi:10.1186/s12883-016-0706-0 · Cited by 28 · see citing works

Controversy: Is Parkinson's disease a single disease entity? Yes

Takahashi, H., & Wakabayashi, K. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.02.011 · Cited by 28 · see citing works

Pick's disease: α- and β-synuclein-immunoreactive Pick bodies in the dentate gyrus

Mori, F., Hayashi, S., Yamagishi, S., Yoshimoto, M., Yagihashi, S., Takahashi, H., & Wakabayashi, K. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0578-9 · Cited by 27 · see citing works

Role of tau versus TDP‐43 pathology on medial temporal lobe atrophy in aging and Alzheimer's disease

Wisse, L. E. M., Wuestefeld, A., Murray, M. E., Jagust, W. J., & Joie, R. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.14582 · Cited by 24 · see citing works

CSF total tau/α-synuclein ratio improved the diagnostic performance for Alzheimer’s disease as an indicator of tau phosphorylation

Shim, K. H., Kang, M. J., Suh, J. W., Pyun, J., Ryoo, N., Park, Y. H., Youn, Y. C., Jang, J., Jeong, J. H., Park, K. W., et al. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00648-9 · Cited by 26 · see citing works

α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization

Feller, B., Fallon, A., Luo, W., Nguyen, P. T., Shlaifer, I., Lee, A. K., Chofflet, N., Yi, N., Khaled, H., Karkout, S., et al. (2023) · Cells · doi:10.3390/cells12071083 · Cited by 22 · see citing works

S2–02–04: The status of a–synuclein in Alzheimer cases with and without Lewy bodies

Halliday, G. M. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.084

Distinct tau and alpha-synuclein molecular signatures in Alzheimer’s disease with and without Lewy bodies and Parkinson’s disease with dementia

van der Gaag, B., Deshayes, N. A. C., Brevé, J. J. P., Bol, J. G. J. M., Jonker, A. J., Hoozemans, J. J. M., Courade, J., & van de Berg, W. D. J. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02657-y · Cited by 45 · see citing works

α‐Synuclein‐positive structures in association with diffuse neurofibrillary tangles with calcification

Hishikawa, N., Hashizume, Y., Ujihira, N., Okada, Y., Yoshida, M., & Sobue, G. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00470.x · Cited by 18 · see citing works

Uncovering α-synuclein and tau burden in Alzheimer’s and Lewy body diseases

Quintin, S. S., Paterno, G., Lloyd, G. M., Prokop, S., & Giasson, B. I. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf324 · Cited by 2 · see citing works

Alpha Synuclein co‐pathology is associated with faster Ab‐related tau accumulation in Alzheimer's disease

Roemer, S. N., Dehsarvi, A., Steward, A., Dewenter, A., Pescoller, J., Wagner, F., Levin, J., Brendel, M., Höglinger, G. U., & Franzmeier, N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.093961 · Cited by 1 · see citing works